2024 Annual Meeting | S3 - General Neurology 1

Date Sunday 04/14/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | Four Seasons 2/3

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Liliana A. Ramirez-Gomez, MD

Topic(s) General Neurology

Learning Objectives A group of abstracts covering a similar topic will be presented in an oral format with presentations lasting eight minutes followed by four minutes of question and answer with the author.

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:12 PM MDT	Abstract	001 - Evaluation of the Impact of Neurology Electronic Consults (E-consults): Experiences of a Neurology Resident Clinic in a County Hospital Lauren Tardo, MD
01:12 PM - 01:24 PM MDT	Abstract	002 - Referral Patterns from Primary Care Clinicians to Specialists Among People with Neurological Disorders Nikki Win
01:24 PM - 01:36 PM MDT	Abstract	003 - Tradipitant Effective in the Reduction of Vomiting Associated with Motion Sickness Across Varied Sea Conditions Vasilios M. Polymeropoulos, MD
01:36 PM - 01:48 PM MDT	Abstract	004 - From Standardization to Specificity: Are We Defining Adverse Events Sufficiently? A Retrospective Cohort Analysis of Neurologic Adverse Event Reporting at NINDS Katherine Landry
01:48 PM - 02:00 PM MDT	Abstract	005 - A Preliminary Analysis of Oral Edaravone-treated Patients with Amyotrophic Lateral Sclerosis Enrolled in a US-based Administrative Claims Database Malgorzata Ciepielewska
02:00 PM - 02:12 PM MDT	Abstract	006 - CGG Repeat Expansion in LRP12 Causes Inherited Peripheral Neuropathy Takahiro Hobara
02:12 PM - 02:24 PM MDT	Abstract	007 - Population Pharmacokinetic Modeling of Riluzole After Administration of a Next Generation Prodrug Troriluzole Heather Sevinsky
02:24 PM - 02:36 PM MDT	Abstract	008 - uSINE-PAMS Artificial Intelligence Driven, Ultrasound-guided Lumbar Puncture to Improve Procedural Accuracy—A Pilot Usability Study Xuling Lin, MD
02:36 PM - 02:48 PM MDT	Abstract	009 - Subarachnoid Hemorrhage Leads to Deficits in Neuronal and Hemodynamic Connectivity James H. Lai
02:48 PM - 03:00 PM MDT	Abstract	010 - Telestroke Outcome Differences Among Neurology Subspecialties Eric J. Seachrist, MD

Faculty Disclosures
Liliana A. Ramirez-Gomez, MD	The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
	No disclosure on file
Siegfried Hirczy, MD	An immediate family member of Dr. Hirczy has received personal compensation for serving as an employee of Meta. Dr. Hirczy has received personal compensation in the range of $500-$4,999 for serving as a Author with Slack Enterprises.
Lauren Tardo, MD	Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NeurologyLive. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Panel member with CanDoMS. Dr. Tardo has a non-compensated relationship as a Tardo with The MOG Project that is relevant to AAN interests or activities.
Shaida Khan, DO	Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chamblee Ryan .
Kyle M. Blackburn, MD	Dr. Blackburn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Amber Salter, PhD	Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers. The institution of Dr. Salter has received research support from Multiple Sclerosis Society of Canada.
Melissa Huynh, MD	Dr. Huynh has nothing to disclose.
Alireza Zandifar, MD	Dr. Zandifar has nothing to disclose.
Masahiro Ando	No disclosure on file
Yujiro Higuchi	No disclosure on file
Akiko Yoshimura	No disclosure on file
Fumikazu Kojima	No disclosure on file
Yutaka Noguchi	No disclosure on file
Akihiro Hashiguchi	No disclosure on file
Hiroshi Takashima, MD, PhD	Dr. Takashima has nothing to disclose.
Eiji Matsuura, MD	Dr. Matsuura has nothing to disclose.
Takahiro Hobara	Dr. Hobara has nothing to disclose.
Jun-Hui Yuan	No disclosure on file
Katherine Landry	No disclosure on file
Matthew Gooden	Matthew Gooden has nothing to disclose.
Sandra Martin	No disclosure on file
Henry Roberts	No disclosure on file
Lauren Reoma, MD, FAAN	Dr. Reoma has received research support from NIH. Dr. Reoma has a non-compensated relationship as a Vice Chair with AAN Experimental Neurotherapeutics Section that is relevant to AAN interests or activities. Dr. Reoma has a non-compensated relationship as a Federal Employee with NINDS/NIH that is relevant to AAN interests or activities. Dr. Reoma has a non-compensated relationship as a Member with ASENT Program Committee that is relevant to AAN interests or activities.
Xuling Lin, MD	The institution of Dr. Lin has received research support from National Health Innovation Center.
Christopher Seet, MBBS	Dr. Seet has nothing to disclose.
Ding Fang Chuang, MBBS	Dr. Chuang has nothing to disclose.
Christen Lim, MBBS	Dr. Lim has nothing to disclose.
Joanne Yuen	No disclosure on file
Liqing Fu	No disclosure on file
Valerie Jun Zhi Teh	No disclosure on file
Seyed Ehsan Saffari	No disclosure on file
AYNUL MARLIYA MOHAMED SULTAN	No disclosure on file
Carissa Lam	No disclosure on file
Yulin Wong	No disclosure on file
Vasilios M. Polymeropoulos, MD	Dr. Polymeropoulos has received personal compensation for serving as an employee of Vanda Pharmaceuticals. An immediate family member of Dr. Polymeropoulos has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Vanda. Dr. Polymeropoulos has stock in Vanda.
Margaret Bushman	No disclosure on file
Dane Morgan	No disclosure on file
Elizabeth Sutherland	No disclosure on file
Tanner Davis	No disclosure on file
Nikolas Pham	No disclosure on file
Leah Kiely	No disclosure on file
Abigail Goldberg	No disclosure on file
Raina Mourad	No disclosure on file
Cameron Miller	No disclosure on file
Changfu Xiao	No disclosure on file
Gunther Birznieks	No disclosure on file
Christos Polymeropoulos	No disclosure on file
Mihael Polymeropoulos	No disclosure on file
Daniel Sheinson	No disclosure on file
Kimberly Jinnett	No disclosure on file
Anisha Patel, PhD	Dr. Patel has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Patel has received personal compensation for serving as an employee of Google. Dr. Patel has stock in Genentech Inc.. An immediate family member of Dr. Patel has stock in Google.
ABHISHEK GAUR	No disclosure on file
Nikki Win	Nikki Win has received personal compensation for serving as an employee of Genentech. Nikki Win has stock in Genentech .
Elizabeth Mearns, PhD	Dr. Mearns has received personal compensation for serving as an employee of Genentech. Dr. Mearns has stock in Genentech.
Christine Macaluso	No disclosure on file
Jonathan Weiss	No disclosure on file
Michael Chopp, PhD	No disclosure on file
Teodora Pene Dumitrescu	No disclosure on file
Yi Shuan Wu	No disclosure on file
Angela Jeong	No disclosure on file
Heather Sevinsky	No disclosure on file
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Richard Bertz	Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
Carrie K. Grouse, MD, FAAN	The institution of Dr. Grouse has received research support from Siemens.
Malgorzata Ciepielewska	Malgorzata Ciepielewska has received personal compensation for serving as an employee of Mitsubishi Tanable Pharma America, Inc..
Jeffrey Zhang	No disclosure on file
Ying Liu	No disclosure on file
Polina Da Silva, Other	Mrs. Da Silva has nothing to disclose.
Björn Tackenberg, MD, FAAN	Dr. Tackenberg has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GILEAD. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tackenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Tackenberg has received stock or an ownership interest from F. Hoffmann-La Roche AG. The institution of Dr. Tackenberg has received research support from Biogen. The institution of Dr. Tackenberg has received research support from Novartis. The institution of Dr. Tackenberg has received research support from Roche.
Eric J. Seachrist, MD	Dr. Seachrist has stock in Medtronic. Dr. Seachrist has stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with American Academy of Neurology that is relevant to AAN interests or activities.
Mohammed M. Sarvath, MD	Dr. Sarvath has nothing to disclose.
Ashley Petrone	No disclosure on file
Amelia K. Adcock, MD	The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Sakina H. Bhatti	Ms. Bhatti has nothing to disclose.
Nina D'Andrea	No disclosure on file
James H. Lai	Mr. Lai has nothing to disclose.
Sanem Aykan	No disclosure on file
Tao Qin	No disclosure on file
David Boas	No disclosure on file
Sava Sakadzic	No disclosure on file
Cenk Ayata, MD	Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quris. Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Ayata has received research support from NIH. The institution of Dr. Ayata has received research support from Takeda. The institution of Dr. Ayata has received research support from Neurelis.
David Y. Chung, MD	Dr. Chung has received research support from NIH/NINDS. Dr. Chung has received research support from The Aneurysm and AVM Foundation.